Lista de obras - Chiara Castelli - Dominio Público Uruguay

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.

artículo científico publicado en 2016

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy

artículo científico publicado en 2014

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

artículo científico publicado en 2014

Antigen recognition by T cells: a strong sense of structure

artículo científico publicado en 2001

Chemokine Receptor 7, A New Player in Regulating Apoptosis of CD8+ T Cells in Cancer Patients

artículo científico publicado en 2005

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types

scientific article published on 29 October 2018

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

artículo científico publicado en 2015

Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors

artículo científico publicado en 1994

Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structures

artículo científico publicado en 1985

Don't run before you can walk

artículo científico publicado en 2012

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).

artículo científico publicado en 2014

Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice

artículo científico publicado en 2004

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response

artículo científico publicado en 2013

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).

artículo científico publicado en 2015

Erratum: Immune mechanisms in neoplasia

scholarly article by Chiara Castelli et al published 2005 in Drug discovery today. Disease mechanisms

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

artículo científico publicado en 2005

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents

artículo científico publicado en 2010

Heat shock proteins and their use as anticancer vaccines.

artículo científico publicado en 2004

Heat shock proteins gp96 as immunogens in cancer patients

artículo científico publicado en 2006

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.

artículo científico publicado en 2003

Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes

article

Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions

artículo científico publicado en 1991

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

artículo científico publicado en 2007

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment

artículo científico publicado en 2014

Immune mechanisms in neoplasia

scholarly article by Chiara Castelli et al published December 2004 in Drug discovery today. Disease mechanisms

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response

artículo científico publicado en 2019

Immune response markers in sentinel nodes may predict melanoma progression

artículo científico publicado en 2014

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

artículo científico publicado en 2002

Immunogenicity of the ALLAVGATK (gp10017 – 25) peptide in HLA-A3.1 melanoma patients ⬇️

artículo científico publicado el 1 de abril de 1998

Immunology and immunotherapy of colorectal cancer

artículo científico publicado en 2003

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.

artículo científico publicado en 2016

Immunotherapy of melanoma

artículo científico publicado en 2003

Improved detection of melanoma antigen‐specific T cells expressing low or high levels of CD8 by HLA‐A2 tetramers presenting a Melan‐A/Mart‐1 peptide analogue ⬇️

artículo científico publicado el 1 de enero de 2002

In Reply

Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.

artículo científico publicado en 2008

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

artículo científico publicado en 2002

Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.

artículo científico publicado en 2008

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites

artículo científico publicado en 2010

Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides

artículo científico publicado en 2012

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity

artículo científico publicado en 2014

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

artículo científico publicado en 1995

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

artículo científico publicado en 2015

Melanoma immunology: past, present and future.

artículo científico publicado en 2007

Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?

scientific article published on 08 November 2008

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

artículo científico publicado en 2014

Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients

scientific article published on 01 January 2014

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity

artículo científico publicado en 2003

NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients

artículo científico publicado en 2007

Natural Killer andNK-LikeT-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96

artículo científico publicado en 2005

P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines

artículo científico publicado en 1989

PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells

artículo científico publicado en 2008

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.

artículo científico publicado en 2002

Phenotypic characterization of human colorectal cancer stem cells

artículo científico publicado en 2007

Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin

artículo científico publicado en 2003

Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells

artículo científico publicado en 2005

Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells

artículo científico publicado en 1991

Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity

artículo científico publicado en 2006

Spheres of Influence in Cancer Stem Cell Biology

scientific article published on 21 October 2010

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma.

artículo científico publicado en 2013

Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours

artículo científico publicado en 2016

T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone

artículo científico publicado en 1990

The T-cell response in patients with cancer

artículo científico publicado en 2002

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression

artículo científico

Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface

artículo científico publicado en 2001

Universal and Stemness-Related Tumor Antigens: Potential Use in Cancer Immunotherapy

artículo científico publicado en 2007

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response

artículo científico

Lista de obras de Chiara Castelli

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

Antigen recognition by T cells: a strong sense of structure

Chemokine Receptor 7, A New Player in Regulating Apoptosis of CD8+ T Cells in Cancer Patients

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors

Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structures

Don't run before you can walk

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).

Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).

Erratum: Immune mechanisms in neoplasia

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents

Heat shock proteins and their use as anticancer vaccines.

Heat shock proteins gp96 as immunogens in cancer patients

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.

Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes

Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment

Immune mechanisms in neoplasia

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response

Immune response markers in sentinel nodes may predict melanoma progression

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

Immunogenicity of the ALLAVGATK (gp10017 – 25) peptide in HLA-A3.1 melanoma patients ⬇️

Immunology and immunotherapy of colorectal cancer

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.

Immunotherapy of melanoma

Improved detection of melanoma antigen‐specific T cells expressing low or high levels of CD8 by HLA‐A2 tetramers presenting a Melan‐A/Mart‐1 peptide analogue ⬇️

In Reply

Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites

Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

Melanoma immunology: past, present and future.

Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity

NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients

Natural Killer andNK-LikeT-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96

P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines

PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.

Phenotypic characterization of human colorectal cancer stem cells

Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: a key role of ezrin

Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells

Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells

Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity

Spheres of Influence in Cancer Stem Cell Biology

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma.

Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours

T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone

The T-cell response in patients with cancer

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression

Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface

Universal and Stemness-Related Tumor Antigens: Potential Use in Cancer Immunotherapy

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response